{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:22:14Z","timestamp":1790284934102,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"crossref","award":["ANR-10-LABX-77"],"award-info":[{"award-number":["ANR-10-LABX-77"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207794","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T18:28:56Z","timestamp":1543602536000},"page":"e0207794","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates"],"prefix":"10.1371","volume":"13","author":[{"given":"Anne-Laure","family":"Flamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Bonnabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lacabaratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Galmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cristillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-5020","authenticated-orcid":true,"given":"Lauren","family":"Hudacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Peltekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0168-3523","authenticated-orcid":true,"given":"Gerard","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"ref1","first-page":"55","article-title":"Elite control of HIV infection: implications for vaccine design","volume":"9","author":"BM Baker","year":"2009"},{"key":"ref2","first-page":"86","article-title":"Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. <italic>Front Immunol<\/italic>","volume":"4","author":"L Genovese","year":"2013","journal-title":"Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load."},{"key":"ref3","first-page":"874","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"TW Chun","year":"1999"},{"issue":"6","key":"ref4","first-page":"576","article-title":"Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change","volume":"11","author":"G Pantaleo","year":"2016"},{"key":"ref5","first-page":"6304","article-title":"IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection","volume":"113","author":"I Sereti","year":"2009"},{"key":"ref6","first-page":"3035","article-title":"Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 <italic>in vivo<\/italic>","volume":"109","author":"SK Pillai","year":"2012"},{"key":"ref7","first-page":"893","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"N Chomont","year":"2009"},{"key":"ref8","first-page":"169","article-title":"Deeks SG. Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"DH Barouch","year":"2014"},{"key":"ref9","first-page":"750","article-title":"Eradicating HIV-1 infection: seeking to clear a persistent pathogen","volume":"12","author":"NM Archin","year":"2014"},{"key":"ref10","first-page":"1","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"RM Steinman","year":"2012"},{"issue":"12","key":"ref11","first-page":"1627","article-title":"Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance","volume":"196","author":"L Bonifaz","year":"2002"},{"key":"ref12","first-page":"255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"L Cohn","year":"2014"},{"key":"ref13","first-page":"705","article-title":"Dendritic cell-targeted vaccines\u2014hope or hype?","volume":"14","author":"W Kastenmuller","year":"2014"},{"issue":"14","key":"ref14","first-page":"4844","article-title":"Phase I Study Utilizing a Novel Antigen-Presenting Cell\u2013Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients","volume":"7","author":"MA Morse","year":"2011"},{"issue":"232","key":"ref15","first-page":"232 ra51","article-title":"Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205","volume":"6","author":"MV Dhodapkar","year":"2014"},{"key":"ref16","first-page":"7131","article-title":"Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates","volume":"108","author":"BJ Flynn","year":"2011"},{"key":"ref17","first-page":"2416","article-title":"Macrophage- and neutrophil-derived TNF-alpha instructs skin langerhans cells to prime antiviral immune responses","volume":"193","author":"O Epaulard","year":"2014"},{"key":"ref18","first-page":"e0135513","article-title":"Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo","volume":"10","author":"AL Flamar","year":"2015"},{"key":"ref19","first-page":"e0153484","article-title":"Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques","volume":"11","author":"G Zurawski","year":"2016"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01596-16","article-title":"Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses","author":"G Zurawski","year":"2017"},{"key":"ref21","first-page":"259","article-title":"Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate","volume":"18","author":"C Klinguer","year":"1999"},{"key":"ref22","first-page":"1039","article-title":"Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults","volume":"20","author":"C Durier","year":"2006"},{"key":"ref23","first-page":"1694","article-title":"Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine","volume":"74","author":"H Gahery-Segard","year":"2000"},{"key":"ref24","first-page":"1239","article-title":"Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers","volume":"15","author":"G Pialoux","year":"2001"},{"key":"ref25","first-page":"2211","article-title":"Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial","volume":"24","author":"D Salmon-C\u00e9ron","year":"2010"},{"key":"ref26","first-page":"405","article-title":"Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals","volume":"20","author":"Y L\u00e9vy","year":"2006"},{"key":"ref27","first-page":"152","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"R Elgueta","year":"2009"},{"key":"ref28","first-page":"2041","article-title":"Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells","volume":"27","author":"AL Flamar","year":"2013"},{"key":"ref29","first-page":"46","article-title":"Functional specialty of CD40 and dendritic cell surface lectins for exogenous antigen presentation to CD8+ and CD4+ T cells","volume":"5","author":"W Yin","year":"2016"},{"key":"ref30","first-page":"1973","article-title":"APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif","volume":"163","author":"EE Bates","year":"1999"},{"key":"ref31","first-page":"1685","article-title":"Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR","volume":"116","author":"E Klechevsky","year":"2010"},{"key":"ref32","first-page":"10","article-title":"Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models&quot;","volume":"5","author":"X Zhu","year":"2007"},{"key":"ref33","first-page":"1668","article-title":"Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment","volume":"21","author":"JA Skinner","year":"2014"},{"key":"ref34","first-page":"823","article-title":"Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity","volume":"4","author":"W Yin","year":"2016"},{"key":"ref35","first-page":"6143","article-title":"Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system","volume":"35","author":"L Cheng","year":"2017"},{"key":"ref36","first-page":"1015","article-title":"Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Non-Human Primates","volume":"195","author":"EA Thompson","year":"2015"},{"issue":"5","key":"ref37","first-page":"367","article-title":"MHC class I A region diversity and polymorphism in macaque species","volume":"59","author":"N Otting","year":"2007"},{"key":"ref38","first-page":"11925","article-title":"Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines","volume":"81","author":"G Gasteiger","year":"2007"},{"key":"ref39","first-page":"149","article-title":"Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer","volume":"5","author":"CM Fehres","year":"2014"},{"key":"ref40","first-page":"2354","article-title":"HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations","volume":"33","author":"N Dereuddre-Bosquet","year":"2015"},{"key":"ref41","first-page":"518","article-title":"DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production","volume":"85","author":"F Meyer-Wentrup","year":"2009"},{"key":"ref42","first-page":"2802","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Y L\u00e9vy","year":"2014"},{"key":"ref43","first-page":"373","article-title":"HIV-1-specific antibody responses during acute and chronic HIV-1 infection","volume":"4","author":"GD Tomaras","year":"2009"},{"key":"ref44","article-title":"TLR3 agonist\/CD40-targeting vaccination induces T cell response and reduces HIV-1 reservoirs","author":"L Cheng","year":"2018"},{"key":"ref45","first-page":"260","article-title":"Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses","volume":"35","author":"BZ Igy\u00e1rt\u00f3","year":"2011"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/eji.201242478","article-title":"CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates","volume":"42","author":"G Romain","year":"2012","journal-title":"Eur. J. Immunol"},{"key":"ref47","first-page":"27","article-title":"Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine","volume":"365","author":"A Cobb","year":"2011"},{"key":"ref48","first-page":"2645","article-title":"Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"189","author":"AL Flamar","year":"2012"},{"key":"ref49","first-page":"63","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"A Harari","year":"2008"},{"key":"ref50","first-page":"360","article-title":"OMIP-005: Quality and phenotype of antigen-responsive rhesus macaque T cells","volume":"81","author":"KE Foulds","year":"2012"},{"key":"ref51","first-page":"182","article-title":"OMIP-016: Characterization of antigen-responsive macaque and human T cells","volume":"83A","author":"S Guenounou","year":"2013"},{"key":"ref52","first-page":"5314","article-title":"Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"S Brandler","year":"2010"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:44:57Z","timestamp":1589042697000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207794"}},"subtitle":[],"editor":[{"given":"Nafees","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207794","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}